VNIM
DXCM icon

Vaughan Nelson Investment Management’s DexCom DXCM Stock Holding History

Vaughan Nelson Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,617,001
Closed -$183M – 211
2024
Q2 		$183M Buy
1,617,001
+203,043
+14% +$25.7M 1.69% 16
2024
Q1 		$196M Buy
1,413,958
+248,111
+21% +$31.2M 1.72% 18
2023
Q4 		$145M Sell
1,165,847
-293,883
-20% -$30M 1.44% 18
2023
Q3 		$136M Buy
1,459,730
+1,451,165
+16,943% +$164M 1.54% 22
2023
Q2 		$1.1M Sell
8,565
-200
-2% -$24.2K 0.01% 186
2023
Q1 		$1.02M Buy
8,765
+4,660
+114% +$522K 0.01% 174
2022
Q4 		$465K Sell
4,105
-2,595
-39% -$285K 0.01% 185
2022
Q3 		$540K Sell
6,700
-4,760
-42% -$403K 0.01% 176
2022
Q2 		$854K Buy
11,460
+4,600
+67% +$420K 0.01% 177
2022
Q1 		$877K Buy
+6,860
New +$750K 0.01% 176

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vaughan Nelson Investment Management's DXCM Position: Q3 2024 in Review

Vaughan Nelson Investment Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 1,617,001 shares — an estimated $183M sold.

Vaughan Nelson Investment Management first reported a position in DXCM in Q1 2022 and held it in 10 quarters. The position peaked at $196M in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Vaughan Nelson Investment Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 1,617,001 DexCom shares in Q3 2024, an estimated $183M.
  • Vaughan Nelson Investment Management first reported a position in DexCom in Q1 2022 and held it in 10 quarters.
  • Vaughan Nelson Investment Management's DexCom position peaked at $196M in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Vaughan Nelson Investment Management's 13F filing for Q3 2024, filed 6 Nov 2024.